AGL vs FMS: stock comparison and AI forecast
Agilon Health, Inc. (AGL) and Fresenius Medical Care Ag (FMS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGL Agilon Health, Inc.
- Price
- $113.39 +86.9% · 6M
- Market Cap
- $1.90B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
FMS Fresenius Medical Care Ag
- Price
- $23.40 +8.1% · 6M
- Market Cap
- $12.15B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- FMS is 6.4 times larger than AGL by market capitalization ($12.15B against $1.90B).
- Over the last six months AGL returned +86.9% and FMS +8.1%.
- FMS turns 4.8% of its revenue into net income, against -1.4% for AGL.
- AGL carries 4.57 times debt per unit of equity, against 1.26 times for FMS.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGL | FMS |
|---|---|---|
| Market Cap | $1.90B | $12.15B |
| P/B Ratio | 6.78x | – |
| EPS | $-5.55 | – |
| Book Value/Share | $16.73 | – |
| Revenue/Share | $357.58 | $65.84 |
| FCF/Share | $-1.01 | – |
Profitability & Margins
| Metric | AGL | FMS |
|---|---|---|
| ROE | -31.0% | 12.2% |
| ROA | -5.6% | – |
| ROIC | -46.3% | – |
| Operating Margin | -2.6% | – |
| Net Margin | -1.4% | 4.8% |
| EBT Margin | -1.7% | – |
| Tax Rate | -4.8% | – |
Financial Health
| Metric | AGL | FMS |
|---|---|---|
| Current Ratio | 1.13x | – |
| D/E Ratio | 4.57x | 1.26x |
| Financial Leverage | 5.57x | – |
| Interest Coverage | 19.5x | 7.4x |
| Working Capital | $166M | – |
Cash Flow
| Metric | AGL | FMS |
|---|---|---|
| Operating Cash Flow | -$4M | – |
| Free Cash Flow | -$17M | – |
| Capital Spending | -$13M | – |
| FCF/Sales | -0.3% | – |
| CapEx/Sales | 0.2% | – |
Operational Efficiency
| Metric | AGL | FMS |
|---|---|---|
| Asset Turnover | 3.84x | – |
| Receivables Turnover | 5.9x | – |
| Fixed Assets Turnover | 249.8x | – |
| Days Sales Outstanding | 62 days | – |
Income Statement
| Metric | AGL | FMS |
|---|---|---|
| Total Revenue | $6.00B | $34.19B |
| Operating Income | -$154M | – |
| Net Income | -$87M | $1.63B |
Dividend & Shareholder Information
| Metric | AGL | FMS |
|---|---|---|
| Shares Outstanding | 17M | 519M |
| Net Income Growth | – | 61.5% |
AGL vs FMS: stock comparison and AI forecast
Which is bigger, AGL or FMS?
FMS is 6.4 times larger than AGL by market capitalization ($12.15B against $1.90B).
Which stock performed better over the last six months, AGL or FMS?
Over the last six months AGL returned +86.9% and FMS +8.1%.
Which one does Intratio's AI model rank higher, AGL or FMS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.